← All diseases Cancer

Hodgkin lymphoma

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchStrongest evidence only (57)Meta-analysis (20)Treatment guideline (1)Systematic review (22)Phase 3 study (8)Randomized trial (6)Clinical trial (606)Review article (177)Early study (phase 1 or 2) (49)Case report (347)Laboratory or animal study (10)Commentary or editorial (20) Studies currently recruiting participants only (49)

Filter

Publications and studies (1992)

• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Decoding the Heterogeneity of Diffuse Large B-Cell Lymphomas: A Comprehensive Genetic, Transcriptomic, and Phenotypic Profiling of B-Cell Lymphoma Cell Lines. (2026/09/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Network structure of depression, anxiety and stress in patients with non-Hodgkin's lymphoma receiving chemotherapy: a multicentre cross-sectional study. (2026/08/10) ♡
• Decade-long persistence of CD19 CAR T cells in B cell lymphomas. (2026/08/10) ♡
• Synchronous Bilateral Adrenal and Central Nervous System Involvement of Extranodal Non-Hodgkin Lymphoma Detected on (18)F-FDG PET/CT. (2026/08/10) ♡
• Survival of U.S. Military Service Members with Hodgkin Lymphoma by Post 9/11 Deployment Status. (2026/08/10) ♡
• Leukaemia and lymphoma radiation risk models from atomic bomb survivors (1950-2001) suitable for lifetime risk calculations. (2026/08/10) ♡
• Long-term follow-up of PET/CT-adapted therapy after three cycles of ABVD for all stages of classic Hodgkin lymphoma: Results of the GATLA LH-05 trial. (2026/08/09) ♡
• Racial/ethnic disparities in risk of second primary malignancies among Diffuse Large B-cell Lymphoma survivors. (2026/08/07) ♡
• Ultrasound-only localisation of a non-palpable cervical lymph node using an UltraCor™ marker for surgical diagnosis of relapsed Hodgkin lymphoma: a case report. (2026/08/07) ♡
• Efficacy and safety of the BEBM (bendamustine, etoposide, busulfan, and melphalan) conditioning regimen for autologous stem-cell transplantation in non-Hodgkin lymphoma. (2026/08/05) ♡
• Targeted Transcriptomic Profiling Identifies Biomarkers and Molecular Features Associated With Immunotherapy Response in Classic Hodgkin Lymphoma. (2026/08/05) ♡
• A bulky cecal lymphoma mimicking colorectal cancer. (2026/08/04) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Complementary roles of (18)F-FDG and (68)Ga-pentixafor PET/CT in gastric MALT lymphoma. (2026/08/04) ♡
• Cutaneous Intravascular Large B-Cell Lymphoma Presenting as Hemophagocytic Lymphohistiocytosis. (2026/08/04) ♡
• Access to Anticancer Drug Trials for Adolescents With Cancer in the United States. (2026/08/03) ♡
• Classic Hodgkin Lymphoma: A Review. (2026/08/03) ♡
• Developing a Symptom Toolkit for Adult Lymphoma Patients Receiving Chemotherapy in Malawi. (2026/08/03) ♡
• [Expert consensus on clinical diagnosis and treatment of pediatric newly diagnosed Hodgkin lymphoma (2026)]. (2026/08/02) ♡
• Spatial proteomics: an interoperable toolbox for analyzing highly multiplexed fluorescence image data. (2026/08/01) ♡
• Haematopoietic cell transplantation for relapsed or refractory classical Hodgkin lymphoma: a retrospective, registry-based cohort study of 19 498 patients from the EBMT Lymphoma Working Group. (2026/08/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. An unusual cranial manifestation of B-cell precursor lymphoblastic lymphoma in 10-year-old girl. (2026/08/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. 18F-FDG PET/CT in Childhood Cancers: Practical Clinical Applications, Pitfalls, and Case-Based Imaging Scenarios. (2026/08/01) ♡
• Rituximab Binding Endows CD20+ Extracellular Vesicles With NK Cell-Activating Properties in B Cell Lymphoma. (2026/08/01) ♡
• Patient- and caregiver-reported barriers to radiotherapy for cancer in sub-Saharan Africa—A survey of population-based registries. (2026/08/01) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Exposure to municipal solid waste incinerators and cancer risk in surrounding populations: A systematic review and meta-analysis. (2026/08/01) ♡
• Novel Integration of Multiple Data Sources in the United States Department of the Air Force Missile Community Cancer Study: A Methodological Analysis. (2026/08/01) ♡
• Further validation of the patient roles and responsibilities scale. (2026/07/31) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Should bilateral (versus unilateral) bone marrow biopsies be routine in paediatric classical Hodgkin Lymphoma where PET-CT is unavailable? (2026/07/31) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Follicular Lymphoma: Novel Therapies and Strategies for Optimal Therapeutic Sequencing. (2026/07/30) ♡
• Detailed analysis of TRBC1 distribution in T-cell subsets and its application in T-cell clonality assessment. (2026/07/30) ♡
• Evaluating the Readability of Patient-Facing Online Educational Materials for Pediatric Leukemia and Lymphoma. (2026/07/30) ♡
• Cancer treatment-related cardiovascular toxicity according to the ESC definition in patients receiving CAR T-cell therapy. (2026/07/30) ♡
• Fulminant Immune Checkpoint Inhibitor-Related Encephalitis (ICI-Encephalitis) Presenting Rapidly After First Infusion of Nivolumab: A Case Report. (2026/07/30) ♡
• Impact of EBV Status and Histology on Patient Outcomes with Nivolumab-AVD vs BV-AVD in Advanced Classic Hodgkin Lymphoma (S1826). (2026/07/29) ♡
• Immune-related adverse events in Hodgkin lymphoma treated with pembrolizumab or nivolumab: A disease-restricted US Food and Drug Administration Adverse Event Reporting System (FAERS) pharmacovigilance analysis. (2026/07/29) ♡
• Cellular Immunity Profile in B-Cell Non-Hodgkin Lymphoma Patients Receiving Rituximab-Based Chemotherapy. (2026/07/29) ♡
• Detection of pathogens in the gut microbiome prior to bloodstream infection in children with acute myeloid leukemia or mature B-cell non-Hodgkin lymphoma. (2026/07/28) ♡
• Optimising survivorship care in Hodgkin's lymphoma: Aligning practice with Ireland's AYA cancer framework. (2026/07/28) ♡
• Diffuse Plane Xanthoma. (2026/07/28) ♡
• Erythema Elevatum Diutinum. (2026/07/28) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Primary Bilateral Adrenal Lymphoma Revealed by Adrenal Insufficiency: From Constitutional Symptoms to Crisis. (2026/07/28) ♡
• Pediatric Synchronous Nasopharyngeal Carcinoma Mimicking Refractory Hodgkin Lymphoma. (2026/07/28) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Paraneoplastic Chronic Recurrent Multifocal Osteomyelitis-Like Bone Disease in Pediatric Hodgkin Lymphoma. (2026/07/27) ♡
• Romiplostim for chemotherapy induced thrombocytopenia in pediatric cancers. (2026/07/25) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Identifying the angiogenic receptor expression in mantle cell lymphoma patients and murine models. (2026/07/24) ♡
• A Bibliometric Analysis of Extranodal NK/T-Cell Lymphoma Research: Trends, Hot Topics, and Future Directions (1999-2026). (2026/07/24) ♡
• Survival by Race and Ethnicity in Children and Adolescents/Young Adults With Relapsed/Refractory Hodgkin Lymphoma: A Pooled Analysis of Children's Oncology Group Trials. (2026/07/24) ♡
• RRx-001 induces apoptosis through reactive oxygen species and endoplasmic reticulum stress in Burkitt lymphoma cells by acting as CD47 and c-Myc regulator. (2026/07/24) ♡
• Safety, feasibility, and efficacy of anti-PD-1 therapy for the treatment of classical Hodgkin lymphoma. (2026/07/23) ♡
• Separating dose schedule from disease biology in CD19 CAR T-cell therapy. Comment on: "A novel dose-dense strategy for CD19-directed CAR T-cell therapy is associated with durable responses without increased toxicity in patients with B-cell non-Hodgkin lymphoma". (2026/07/23) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.